Results 101 to 110 of about 4,450 (205)

Stressing the limits of capillary blood in anti-doping analysis: perspectives on alkylamine-like stimulants and carbonic anhydrase II inhibitors in result management. [PDF]

open access: yesFront Sports Act Living
da Costa Nunes IK   +7 more
europepmc   +1 more source

Dorzolamida en el tratamiento del edema quístico macular poscirugía de catarata

open access: yesRevista Cubana de Oftalmología
RESUMEN El edema quístico macular es, actualmente, una de las complicaciones posoperatorias más prevalentes después de la cirugía de cataratas. En no pocos casos acarrea una disminución en la agudeza visual posquirúrgica de los pacientes.
Elianne Perera Miniet   +5 more
doaj  

Synergistic antidiabetic efficacy of dorzolamide and metformin: HPTLC quantification and biological evaluation. [PDF]

open access: yesSci Rep
Abdel-Hafez NG   +5 more
europepmc   +1 more source

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study

open access: yes, 2018
Aims-To compare the effects on intraocular pressure (IOP) and side effects of monotherapy with either latanoprost or dorzolamide in patients with glaucoma or ocular hypertension.
O\u27Donoghue, E P
core  

Macular Edema Without Vascular Leakage - The Diagnostic Challenge of SNIFR and its Differential Diagnoses. [PDF]

open access: yesKlin Monbl Augenheilkd
Näther S   +5 more
europepmc   +1 more source

Traitement des glaucomes par les inhibiteurs de l'anhydrase carbonique en collyre: expérience rétrospective à moyen terme du dorzolamide

open access: yes, 1997
Clinical evaluation of the efficacy and innocuity of dorzolamide, the first new born topical carbonic anhydrase inhibitor. Our retrospective analysis included 162 patients (76 men, 86 women) who were exclusively followed in our department and treated ...
Detry-Morel, Michèle, De Hoste, F.
core  

Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy. [PDF]

open access: yesMedicina (Kaunas)
Sanseau A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy